title: Sever sepsis after probiotic treatment with Escherichia coli NISSLE 1917.
authors.forename: Katrin
authors.initials: K
authors.lastname: Guenther
authors.forename: Eberhardt
authors.initials: E
authors.lastname: Straube
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Pfister
authors.forename: Albrecht
authors.initials: A
authors.lastname: Guenther
authors.forename: Axel
authors.initials: A
authors.lastname: Huebler
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015373:Bacterial Typing Techniques; D001769:Blood / Q000382:microbiology; D016172:DNA Fingerprinting; D016521:Electrophoresis, Gel, Pulsed-Field; D004926:Escherichia coli / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D005838:Genotype; D006801:Humans; D007231:Infant, Newborn; D019936:Probiotics / Q000008:administration & dosage* / Q000009:adverse effects*; D018805:Sepsis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents